Detailed answers about OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED, including incorporation, status, business activity, and accounts information.
When was OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED founded?
OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED was officially incorporated on 31 January 2018 and is registered under company number 11180686. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED?
OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED do?
OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED operates in the following sectors: 74909 - Other professional, scientific and technical activities n.e.c., 85590 - Other education n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED's registered address?
The registered office address of OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED is BUXTON COURT, 3 WEST WAY, OXFORD, 3 WEST WAY, OXFORD, ENGLAND, OX2 0JB. This is the official address filed with Companies House for legal and statutory correspondence.
Is OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED financially stable?
The most recent accounts for OXFORD MOLECULAR MEDICINE TECHNOLOGY LIMITED were made up to 31 July 2024, filed as DORMANT. Next accounts are due by 30 April 2026.